OSET

Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business

Retrieved on: 
Thursday, November 2, 2023

BEDFORD, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its third quarter ended September 30, 2023.

Key Points: 
  • Revenue in the third quarter of 2023 was $41.5 million, up 3% compared to $40.3 million in the third quarter of 2022.
  • Adjusted EBITDA2 was $4.7 million, compared to $4.1 million in the third quarter of 2022.
  • Anika’s management will hold a conference call and webcast to discuss its financial results and business highlights today, Thursday, November 2, 2023, at 5:30 pm ET.
  • A slide presentation with highlights from the conference call will be available in the Investor Relations section of the Anika website.

Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting

Retrieved on: 
Tuesday, September 19, 2023

BEDFORD, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company, today announced the full market release of their RevoMotion Reverse Shoulder Arthroplasty System (RSA) at the 2023 Orthopaedic Summit (OSET) Annual Meeting on September 20-23 in Boston, MA. Throughout the event, Anika will feature the RevoMotion RSA as well as the recently cleared Integrity Implant System and the recently launched X-Twist Fixation System at Booth #304 and during various educational opportunities throughout the conference.

Key Points: 
  • Integrity has an innovative delivery and fixation system and has greater regenerative capacity compared to first generation collagen patches.
  • “The RevoMotion Reverse Shoulder Arthroplasty System fills a vital place in Anika’s shoulder arthroplasty portfolio, which now offers the full line of solutions to meet my patients’ needs,” said Christopher Baker, M.D., Florida Orthopaedic Institute, Tampa, Florida.
  • Furthermore, Anika will have the newly cleared Integrity Implant System available for preview and demonstration at the booth.
  • The Integrity Implant System was fully cleared by the FDA in August 2023 with market launch targeted for Q1-2024, view press release here .

World-Renowned Orthopaedics Pioneer Joseph D. Zuckerman, MD, Receives Lifetime Achievement Award

Retrieved on: 
Wednesday, September 20, 2023

"In our 13th year of the Orthopaedic Summit, I couldn't be prouder to present the Lifetime Achievement Award to Joseph D. Zuckerman," said Kevin Plancher, MD, MPH, FAOA, FAAOS, Founder of the Orthopaedic Summit, Clinical Professor of Orthopaedics at Albert Einstein College of Medicine.

Key Points: 
  • "In our 13th year of the Orthopaedic Summit, I couldn't be prouder to present the Lifetime Achievement Award to Joseph D. Zuckerman," said Kevin Plancher, MD, MPH, FAOA, FAAOS, Founder of the Orthopaedic Summit, Clinical Professor of Orthopaedics at Albert Einstein College of Medicine.
  • "I am honored OSET chose to award me the Lifetime Achievement award," Zuckerman said.
  • I would like to thank my colleagues for their passion and sharing the same vision to advance the field of orthopaedics.
  • "Dr. Zuckerman's extensive knowledge, leadership and professionalism exemplifies why he is a recipient of the Lifetime Achievement award," said Exactech Vice President of Extremities Marketing Emery Patton.

Anika Reports Second Quarter 2023 Financial Results

Retrieved on: 
Tuesday, August 8, 2023

BEDFORD, Mass., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its second quarter ended June 30, 2023.

Key Points: 
  • Revenue in the second quarter of 2023 was $44.3 million, up 12% compared to $39.7 million in the second quarter of 2022.
  • Adjusted EBITDA2 was $6.3 million, compared to $4.4 million in the second quarter of 2022.
  • Ending cash balance was $65.1 million, after $5.0 million used to repurchase shares of Anika stock in the second quarter.
  • Anika’s management will hold a conference call and webcast to discuss its financial results and business highlights today, Tuesday, August 8, 2023, at 5:00 pm ET.

The 13th Annual Orthopaedic Summit Returns to Boston

Retrieved on: 
Tuesday, March 28, 2023

STAMFORD, Conn., March 21, 2023 /PRNewswire/ -- OSET (Orthopaedic Summit: Evolving Techniques), the 501(c)3 non-profit organization that specializes in the educational advancement of each orthopaedic subspecialty including Total Joint Arthroplasty (Knee, Hip, Shoulder), Sports Medicine (Knee, Shoulder, Elbow), Trauma, Spine, Minimally Invasive Surgery and Arthroscopy, today announced that it will return to Boston for its 13th Annual Meeting, which will be held at the Boston Marriott Copley Place from September 20 – 23, 2023. Surgeons, Fellows, Residents, Medical Students, Physician Assistants, Nurse Practitioners, Athletic Trainers, Physical and Occupational Therapists, and Industry Partners from across the globe will gather together at the event to collaborate and develop innovative strategies to enhance musculoskeletal patient care.

Key Points: 
  • Boston Marriott Copley Place on September 20-23, 2023
    STAMFORD, Conn., March 21, 2023 /PRNewswire/ -- OSET (Orthopaedic Summit: Evolving Techniques), the 501(c)3 non-profit organization that specializes in the educational advancement of each orthopaedic subspecialty including Total Joint Arthroplasty (Knee, Hip, Shoulder), Sports Medicine (Knee, Shoulder, Elbow), Trauma, Spine, Minimally Invasive Surgery and Arthroscopy, today announced that it will return to Boston for its 13th Annual Meeting, which will be held at the Boston Marriott Copley Place from September 20 – 23, 2023.
  • The Executive Education Committee has again selected Boston to allow for continued growth of all aspects of the meeting while drawing upon the city's vibrant offerings.
  • "I am honored to be hosting the Orthopaedic Summit in my hometown of Boston, and look forward to the continued growth of the course," said Brian D. Busconi, M.D., Associate Professor of Orthopedics and Physical Rehabilitation Pediatrics and Family Medicine and Community Health at Massachusetts Medical School and Conference Chair of Orthopaedic Summit.
  • "We have just released the scientific program for 2023 and could not be more enthusiastic to return to Boston."

Dana DeBeauvoir, Renowned Election and Public Administration Expert Joins OSET Institute Board of Directors

Retrieved on: 
Tuesday, November 1, 2022

The OSET Institute today announced that Dana DeBeauvoir , a nationally recognized authority on election administration and integrity, has joined the organizations Board of Directors.

Key Points: 
  • The OSET Institute today announced that Dana DeBeauvoir , a nationally recognized authority on election administration and integrity, has joined the organizations Board of Directors.
  • Ms. DeBeauvoir won several state and national awards for her forward-thinking ideas on election administration and is recognized as a national leader in election administration and security.
  • The National Association of Election Officials (Election Center) also awarded Dana with the Minute Man Award for developing a scalable and effective election security practice for election officials.
  • We are thrilled to have Dana join the OSET Institutes Board, said OSET co-founder and COO, Gregory Miller.

OSET Institute Releases “Murphy’s Guide to Likely Dysfunction in the 2022 Midterm Election”

Retrieved on: 
Monday, October 31, 2022

The 2022 Midterm Election on November 8, 2022 is rightly anticipated to be one of the most divisive and consequential elections in recent U.S. history.

Key Points: 
  • The 2022 Midterm Election on November 8, 2022 is rightly anticipated to be one of the most divisive and consequential elections in recent U.S. history.
  • As it has in the past two election cycles, the OSET Institute has published the Murphys Guide to Likely Dysfunction in the 2022 Midterm Election in order to put a spotlight on the range of possible issues for the upcoming Midterm Election.
  • However, this midterm election has the potential to be fraught with issues, claims, and chaos in the days and weeks following election day.
  • OSET Institute experts in election administration and related technology and process are available to discuss any or all of these issues upon request.

World Renowned Medical Pioneer, Inventor, Mentor, 94 Year-Old Orthopaedic Surgeon William H. Harris, MD, Receives Lifetime Achievement Award

Retrieved on: 
Thursday, September 29, 2022

Harris, MD, (pictured at far right)Founder and Director Emeritus of the Massachusetts General Hospital ,Harris Orthopaedics Laboratory.

Key Points: 
  • Harris, MD, (pictured at far right)Founder and Director Emeritus of the Massachusetts General Hospital ,Harris Orthopaedics Laboratory.
  • (Picturedsecond from left) is Orthopaedic Surgeon Kevin D. Plancher, MD, MPH, Founder of OSET and Ivan Tornos, President & COO of Zimmer Biomet (pictured third from left).
  • His laboratory helped unravel a totally new, destructive disease damaging total hip and total knee reconstruction.
  • Orthopaedic Summit Evolving Techniques (OSET) is a 501c3 organization founded by Orthopaedic Surgeon, Kevin D. Plancher, MD, MPH, FAOA, FAAOS, FACS, and Conference Chair, Brian D Busconi, MD of UMASS Medical Center in 2010.

94-Year-Old, Orthopaedic Surgeon William H. Harris, M.D., World-Renowned Medical Pioneer, Inventor, Mentor, Receives Lifetime Achievement Award

Retrieved on: 
Wednesday, September 28, 2022

They then innovated a new material which improved the new prosthetic bearing surface, eliminating that bone destruction and greatly extending the life of total joint implants.

Key Points: 
  • They then innovated a new material which improved the new prosthetic bearing surface, eliminating that bone destruction and greatly extending the life of total joint implants.
  • "I am honored to have the opportunity to have presented this Lifetime Achievement Award to Dr. Harris.
  • His Harris Harvard Hip Course was the seminal course that set the bar for education in total joints for years to come."
  • Harris has not only impacted future generations of surgeons but has played an integral role in collaborating with industry to design life-changing, disruptive technologies.

Moximed’s MISHA™ Knee System Achieves Superiority of Primary Endpoint in Pivotal Study

Retrieved on: 
Thursday, September 22, 2022

Voshell Professor of Sports Medicine, Department of Sports Medicine, University of Virginia, presented results from the pivotal Calypso Study of the MISHA Knee System, an implantable shock absorber (ISA) for the treatment of knee osteoarthritis.

Key Points: 
  • Voshell Professor of Sports Medicine, Department of Sports Medicine, University of Virginia, presented results from the pivotal Calypso Study of the MISHA Knee System, an implantable shock absorber (ISA) for the treatment of knee osteoarthritis.
  • The Calypso Study demonstrated superiority of its primary endpoint and reported clinically significant reduction in pain scores and improvement in function scores for participants receiving the MISHA Knee System.
  • Over 90% of the patients receiving the MISHA Knee System experienced substantial, clinically meaningful pain relief and functional improvement.
  • In Dr. Diduchs data presentation of the Calypso Study, the MISHA Knee System met its primary endpoint and was found to be superior to high tibial osteotomy at two years.